Abstract 3893: Enhanced detection of molecular subtypes in prostate cancer using saturation biopsy: Insights into tumor heterogeneity and racial disparities
Wei Zhao(Henry Ford Health System), Nallasivam Palanisamy(Henry Ford Health System), Dhananjay Chitale(Henry Ford Hospital), Firas Abdollah(Henry Ford Health System), J Ryba(Instituto de Diagnóstico e Investigaciones Metabólicas), Pin Li(Chinese Academy of Sciences), Wooju Jeong(Henry Ford Hospital), Nilesh Gupta(Henry Ford Health System), Shannon Carskadon(Henry Ford Health System), Daniel Isaac(McLaren Greater Lansing), Hristina Trpevski(Henry Ford Health System), Craig Rogers(Norfolk and Norwich University Hospitals NHS Foundation Trust)
Cited by 0
Related Papers
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth
|JAMA|2015|420
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
|Clinical Cancer Research|2013|358
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma
|Modern Pathology|2014|227
ERG gene rearrangements are common in prostatic small cell carcinomas
|Modern Pathology|2011|219